Abstract:Objective:To promote the rational use of antiplatelet drugs by analyzing the characteristics of platelet aggregation function through the standardized detection technology, and determining the association between platelet aggregation function and age in apparently healthy elderly Chinese.Methods:In this study, 5 658 apparently healthy elderly participants aged ≥60 years were enrolled from 6 hospitals between January 1, 2018 and August 31, 2019. The platelet aggregation rate induced by arachidonic acid (AA) and adenosine diphosphate (ADP) was detected by a standardized automatic platelet aggregation instrument, and the platelet aggregation rate induced by AA and ADP among various age groups (60-69, 70-79 and 80-89 years) was analyzed. Reference intervals were defined according to CLSI document C28-A3 using the nonparametric method ( P2.5 and P97.5 were used to determine the 95% confidence interval). Results:The platelet aggregation rates induced by AA and ADP was similar between hospitals by standardized platelet detection techniques (all P>0.05). Among 5 658 patients, 2 633 (46.54%) received AA-induced platelet aggregation test, and the AA-induced platelet aggregation rate was significantly higher in the 70-79 and 80-90 years groups than that in the 60-69 years group ([72.35±11.67]% and [72.67±11.45]% vs [70.65±12.57]%, all P<0.001), while which was similar between the 70-79 years and 80-90 years groups ( P=0.840). ADP-induced platelet aggregation rate was detected in 3 025 participants (53.46%), and there was no statistically significant difference among all age groups ( P=0.654). The recommended reference interval for AA-induced platelet aggregation was 37.12%-88.47% for people aged 60-69 years, and 37.45%-88.97% for people aged 70-90 years. The recommended reference interval for ADP-induced platelet aggregation rate is 47.95%-92.11%. Conclusions:The results of platelet aggregation are consistent across laboratories using standardized testing systems through standardized testing procedures. It is necessary to establish a reference range for the platelet aggregation rate induced by AA in the elderly people aged 60-69 and older than 70 years, while the platelet aggregation rate induced by ADP does not require a separate reference range for the platelet aggregation rate in the elderly.

The disparity of platelet factor 4 and platelets in individuals of different ages

Platelet aggregation function in apparently healthy elderly Chinese: results from a multi-center investigation

Platelet Factor 4 (PF4) Regulates Hematopoietic Stem Cell Aging

In platelet single donor apheresis, platelet factor 4 levels correlated with donor's age and decreased during storage

Platelet factors attenuate inflammation and rescue cognition in ageing

Dynamic and Functional Linkage Between Von Willebrand Factor and ADAMTS-13 with Aging: an Atherosclerosis Risk in Community Study.

Platelet function and ageing

Platelet-Rich Plasma in Young and Elderly Humans Exhibits a Different Proteomic Profile

An age-specific platelet differentiation path from hematopoietic stem cells contributes to exacerbated thrombosis

Platelet life cycle during aging: function, production and clearance

An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis

Platelet factors are induced by longevity factor klotho and enhance cognition in young and aging mice

What can we learn from senescent platelets, their transcriptomes and proteomes?

Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders

Age-Dependent Surface Receptor Expression Patterns in Immature Versus Mature Platelets in Mouse Models of Regenerative Thrombocytopenia

Correlation of bioactive components of platelet rich plasma derived from human female adult peripheral blood and umbilical cord blood with age

Aging Is Associated With Organ-Specific Alterations in the Level and Expression Pattern of von Willebrand Factor

Platelet transcriptome profiles provide potential therapeutic targets for elderly acute myelocytic leukemia patients

Study on Impact of Recipients Age on Clinical Platelets Transfusion

Platelet Aging In Vivo Is Associated with Loss of Membrane Phospholipid Asymmetry

The platelet transcriptome and proteome in Alzheimer's disease and aging: an exploratory cross-sectional study